MTLS Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne

03
Kurs $8.50
P/E 42.7
EPS $0.13
Umsatz $268M
ROE 3.1%
52W-Spanne $5–$9

MTLS Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen

04
Spanne
Balken

Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.

Über Materialise NV - American Depositary Shares Unternehmensübersicht von Wikipedia

05 · wikidata

Materialise NV, headquartered in Leuven, Belgium, is a company in the 3D printing / additive manufacturing sector.

History

1990s

Materialise was founded in June 1990 by Wilfried Vancraen and his wife Hilde Ingelaere as a Rapid Prototyping service bureau. It was the first company of its kind in the Benelux region of Europe, through the acquisition of a single Stereolithography machine (the SLA 1).

In 1992, Materialise began mapping human anatomy digitally in three dimensions, using sliced CT image data, which lead to the development of its medical image processing software: Mimics. Concurrently, the team was also developing its industrial software solution, Magics. Both of these software solutions were later commercialized to promote growth.

In 1995, Materialise became the first company to produce 3D printed parts in more than one colour, specifically at this time for anatomical models produced using the stereolithography process to delineate the complexities of the anatomy (such as nerves, blood vessels and tumours) and allow surgeons to more precisely plan for operations.

The company developed and produced the first customised 3D printed surgical guide for a dental operation in 1996. These personalised guides were utilised during surgery to show surgeons bone cutting and drilling locations to apply implants. This knowledge was used to develop Materialise SimPlant software, allowing the surgeon to virtually plan the surgery and minimize invasive exploratory surgery.

The company launched one of the first 3D printing online ordering systems in 1997, Materialise NextDay, which later became Materialise OnSite. This service allowed 3D printing service customers to send digital 3D data, which could be printed and shipped the next day.

Demand for prototypes grew, leading Materialise to develop its Mammoth Stereolithography systems, which are capable of printing single-piece models with dimensions of more than 2 meters in the Y axis.

2000s

In the year 2000, hearing aid specialist Phonak approached Materialise to develop the Rapid Shell Modeling (RSM) software. This allowed the design process for customized, patient-specific hearing aid shells to become automated. The resulting designs could then be 3D printed to produce the customised hearing aids. This was the first high volume, end-use application of 3D printing, and today, 99% of the world's hearing aids are now produced using 3D printing.

Materialise acquired US company Columbia Scientific Inc, (CSI) in 2001, the creators of Sim/Plant and ImageMaster, which became the US headquarters for Materialise's dental division in that region.

In 2003 Materialise launched one of the first 3D printed consumer brands — .MGX by Materialise — for 3D printing end-use products as well as prototypes. In parallel, the company also acquired Fused Deposition Modelling (FDM) systems for industrial applications.

The following year, in 2004, Materialise introduced its 3-matic software, allowing 3D printer users to edit files directly in the STL format. Previously, if design changes were required in the digital model, designers had to make them in the CAD suite of choice before re-converting the entire file to STL again.

In 2006 Materialise launched RapidFit, developed as a 3D printed solution for shipping large parts with customized jigs and fixtures to prevent deformation or breakage while in transit.

In 2006 Materialise developed the first Titanium 3D printed skull implants, following the acquisition of OBL, which specialized in the creation of custom cranio-maxillfacial (CMF) implants, producing customized implants with intricate porous structures, that behave like natural bone and mimic its mechanical and thermal properties.

In 2008 Materialise introduced the e-Stage software which was the first software to automatically generate support structures for different geometries in Stereolitography. In the same year, the company launched i.materialise for the consumer market, making it possible for anyone to print their ideas using professional-quality equipment. Materialise also developed its first Build Processor to support running different 3D printing processes more efficiently within a single location.

2010s

In 2012, Materialise introduced Streamics to provide traceable quality control to industrial 3D printer users producing end-use parts within regulated industries.

Materialise went public on June 25, 2014 to enable expansion of its services and software development. The same year the company acquired OrthoView, a market leader in orthopaedic digital pre-operative planning software founded by Adrian Dwyer, John Chambers, and Peter Quinn, and officially established a new office in China in December with a focus on 3D printing Software and R&D, namely Materialise Shanghai Co. Ltd.

In 2016, the company opened a new and dedicated metal production facility in Bremen, Germany. Materialise HQ, Leuven, also acquired and started testing the multi jet fusion (MJF) process from HP. Production of parts with MJF started in the following year, 2017.

With the expansion of the AM Metal market, Materialise acquired ACTech in Germany to extend the company's metal capabilities, with a specific emphasis on low-volume production of highly complex metal parts. The acquisition also enabled Materialise to develop and improve its software suite for metal 3D printing.

== References ==

Quelle: Wikipedia (Englisch), CC BY-SA 4.0 · Auf Wikipedia ansehen ↗

Wikidata ↗

SektorTechnology BrancheTechnology Mitarbeiter2.556 LandBE

10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends

06
Umsatz$268M
2016-12-31 → 2025-12-31
EPS$0.13
2016-12-31 → 2025-12-31
Freier Cashflow$11M
2021-12-31 → 2025-12-31
Nettogewinnmarge2.9%
2017-12-31 → 2025-12-31
Bewertung & Kennzahlen 07–12

Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?

Kennzahl 5-Jahres-Trend MTLS 5-Jahres-Durchschnitt Peer-Median Fazit
P/E 42.75-Jahres-Durchschnitt ≈3.4 ≈3.4 · ·

Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.

Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median

Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum

14
Durchschn. Überraschung 89.3%
ZeitraumBerichtEPS ActualEPS est.Überraschung
30. Juni 2026 $0.07 $0.04 71.6%
31. März 2026 $0.03 $0.01 194.1%
31. Dezember 2025 $0.11 $0.06 79.7%
30. September 2025 $0.04 $0.01 292.2%
30. Juni 2025 $0.00 $0.02 -100.0%
31. Dezember 2024 $0.05 $0.05 -2.0%

Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow

15
Gewinn- und Verlustrechnung 15
Kennzahl Trend 2025202420232022202120202019201820172016
Revenue $268M$267M$256M$232M$205M$170M$197M$185M$143M$114M
Cost of Revenue $115M$116M$111M$103M$87M$76M$87M$82M$63M$47M
Gross Profit $153M$151M$145M$129M$118M$94M$110M$102M$80M$68M
R&D Expense $46M$44M$38M$38M$27M$27M$23M$22M$20M$18M
Operating Income $9M$9M$6M$-3M$12M$-5M$7M$5M$392.0K$107.0K
Interest Expense $2M$1M$2M$2M$2M$2M$2M$2M$1M$665.0K
Interest Income $4M$8M$5M$6M$6M$2M$1M$4M$3M$2M
Pretax Income $7M$14M$7M$-1M$14M$-8M$4M$3M$-2M$-1M
Income Tax $-429.0K$733.0K$78.0K$975.0K$591.0K$-1M$3M$425.0K$522.0K$2M
Net Income $8M$13M$7M$-2M$13M$-7M$2M$3M$-2M$-3M
EPS (Basic) $0.13$0.23$0.11$-0.04$0.23$-0.13$0.03$0.06$-0.04$-0.06
EPS (Diluted) $0.13$0.23$0.11$-0.04$0.23$-0.13$0.03$0.06$-0.04$-0.06
Shares (Basic) 59,067,00059,067,00059,067,00059,064,00056,685,00053,364,00052,91549,80647,32547,325
Shares (Diluted) 59,072,00059,105,00059,085,00059,064,00056,843,00053,364,00053,98750,69747,32547,325
EBITDA $31M$9M$6M$-3M$12M$-5M$7M$5M$865.0K·
Bilanz 10
Kennzahl Trend 2025202420232022202120202019201820172016
Cash & Equivalents $134M$102M$128M$141M$196M$112M$129M$116M$43M$56M
Inventory ··$17M$16M$11M$10M$13M$10M$11M$8M
Current Assets $224M$191M$206M$216M$258M$161M$191M$169M$97M$96M
PP&E (Net) $113M$111M$95M$94M$84M$88M$91M$93M$87M$45M
Goodwill $43M$43M$43M$44M$19M$19M$20M$17M$18M$9M
Intangibles $26M$30M$31M$38M$32M$33M$27M$26M$29M$10M
Total Assets $421M$396M$397M$411M$413M$326M$349M$313M$235M$162M
Current Liabilities $92M$102M$105M$106M$91M$84M$84M$73M$63M$48M
Retained Earnings $27M$19M$6M$-1M$965.0K$-7M$-272.0K$-2M$-4M$-2M
Stockholders' Equity $256M$249M$237M$229M$233M$133M$140M$136M$77M$79M
Cashflow 8
Kennzahl Trend 2025202420232022202120202019201820172016
D&A $22M$22M$22M·······
Other Non-cash $-4M·········
Operating Cash Flow $25M$31M$20M$22M$26M$30M$28M···
CapEx $14M$25M$9M$22M$8M$11M$13M···
Investing Cash Flow $-10M$-29M$-11M$-54M$-13M$-28M$-26M···
Financing Cash Flow $17M$-28M$-22M$-23M$71M$-17M$11M···
Free Cash Flow $11M$7M$11M$680.0K$18M·····
Levered FCF $9M$6M$9M$-3M$16M·····
Rentabilität 8
Kennzahl Trend 2025202420232022202120202019201820172016
Gross Margin 57.1%56.5%56.7%55.5%57.5%55.1%55.8%55.5%56.0%·
Operating Margin 3.3%3.5%2.2%-1.2%5.9%-2.7%3.6%2.8%0.61%·
Net Margin 2.9%5.0%2.6%-0.91%6.4%-4.2%0.84%1.6%-1.2%·
Pretax Margin 2.7%5.3%2.6%-0.51%6.7%-4.8%2.2%1.9%-0.79%·
EBITDA Margin 11.5%3.5%2.2%-1.2%5.9%-2.7%3.6%2.8%0.61%·
ROA 1.9%3.4%1.7%-0.51%3.6%-2.1%0.50%1.1%-0.83%·
ROE 3.1%5.5%2.9%-0.92%7.2%-5.2%1.2%2.8%-2.1%·
ROIC 3.7%3.6%2.4%-2.3%5.0%-3.1%2.0%3.3%0.58%·
Liquidität & Solvenz 3
Kennzahl Trend 2025202420232022202120202019201820172016
Current Ratio 2.41.92.02.02.81.92.32.31.5·
Quick Ratio 1.51.01.21.32.11.31.51.60.7·
Interest Coverage 5.27.33.2-1.45.0-2.03.33.0-0.8·
Effizienz 2
Kennzahl Trend 2025202420232022202120202019201820172016
Asset Turnover 0.70.70.60.60.60.50.60.70.7·
Inventory Turnover ··6.77.58.26.77.77.8-6.5·
Pro Aktie 3
Kennzahl Trend 2025202420232022202120202019201820172016
Revenue / Share $4.53$4.51$4.33$3.93$3614.34$3194.08$3643.08$3649.96$3.01·
Cash Flow / Share $0.43$0.53$0.34$0.38$454.67·····
EPS (TTM) $0.13$0.23$0.11$-0.04$0.23$-0.13$0.03$0.06$-0.04·
Bewertung (TTM) 4
Kennzahl Trend 2025202420232022202120202019201820172016
Revenue TTM $268M$267M$256M$232M$205M$170M$197M$185M$143M·
Net Income TTM $8M$13M$7M$-2M$13M$-7M$2M$3M$-2M·
P/E 42.730.659.7-220.0103.8-417.0610.3330.0-284.3·
Earnings Yield 2.3%3.3%1.7%-0.45%0.96%-0.24%0.16%0.30%-0.35%·

Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt

Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre

16
Kennzahl 2025-12-312024-12-312023-12-312022-12-312021-12-31
Umsatz $268M $267M $256M $232M $205M
Bruttogewinnmarge % 57.1% 56.5% 56.7% 55.5% 57.5%
Betriebsgewinnmarge % 3.3% 3.5% 2.2% -1.2% 5.9%
Nettoergebnis $8M $13M $7M $-2M $13M
Verwässerte EPS $0.13 $0.23 $0.11 $-0.04 $0.23

Institutionelle Eigentümer (13F) 66 Einreicher · $57.8M gesamt · Stand 30. Juni 2026

17

Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.

Inhaber 66
Gehaltener Wert $57.8M
Neue Positionen 7
Geschlossene Positionen 9
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
Neue Positionen Geschlossene Positionen Erhöht Abgenommen Nettoveränderung der Aktien
7 (-4 vs. Vorquartal) 9 (+2 vs. Vorquartal) 15 (-1 vs. Vorquartal) 23 (+2 vs. Vorquartal) +519K

Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.

Institution Wert Aktien % der verfolgten 13F Typ
DISCIPLINED GROWTH INVESTORS INC /MN $14.803.837 1.992.441 25,60% Aktien
Rock Point Advisors, LLC $7.362.172 990.871 12,73% Aktien
Archon Capital Management LLC $5.696.001 766.622 9,85% Aktien
KING LUTHER CAPITAL MANAGEMENT CORP $4.671.613 628.750 8,08% Aktien
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $3.544.006 476.986 6,13% Aktien
ARK Investment Management LLC $3.118.995 419.784 5,39% Aktien
RENAISSANCE TECHNOLOGIES LLC $2.200.766 296.200 3,81% Aktien
CITADEL ADVISORS LLC $1.828.649 246.117 3,16% Aktien
EDMOND DE ROTHSCHILD HOLDING S.A. $1.486.052 200.007 2,57% Aktien
SUSQUEHANNA INTERNATIONAL GROUP, LLP $1.171.711 157.700 2,03% Verkaufsoption
AMH Equity Ltd $1.156.672 207.661 2,00% Aktien
CREDIT AGRICOLE S A $1.120.184 150.765 1,94% Aktien
MORGAN STANLEY $1.110.153 149.415 1,92% Aktien
UBS Group AG $915.561 123.225 1,58% Aktien
TWO SIGMA INVESTMENTS, LP $746.916 100.527 1,29% Aktien
NANO CAP NEW MILLENNIUM GROWTH FUND L P $743.000 100.000 1,28% Aktien
AXA Investment Managers S.A. $636.250 114.228 1,10% Aktien
Quinn Opportunity Partners LLC $594.422 80.003 1,03% Aktien
MILLENNIUM MANAGEMENT LLC $500.069 67.304 0,86% Aktien
LPL Financial LLC $371.195 49.959 0,64% Aktien
Trexquant Investment LP $302.787 40.752 0,52% Aktien
XTX Topco Ltd $297.475 40.037 0,51% Aktien
MERITAGE PORTFOLIO MANAGEMENT $295.637 53.268 0,51% Aktien
SUSQUEHANNA INTERNATIONAL GROUP, LLP $278.313 37.458 0,48% Aktien
JANE STREET GROUP, LLC $268.810 36.179 0,46% Aktien
Engineers Gate Manager LP $257.992 34.723 0,45% Aktien
STATE STREET CORP $232.670 31.315 0,40% Aktien
TWO SIGMA ADVISERS, LP $229.770 41.400 0,40% Aktien
JANE STREET GROUP, LLC $219.928 29.600 0,38% Kaufoption
Argos Wealth Advisors, LLC $217.090 29.218 0,38% Aktien
JPMORGAN CHASE & CO $211.943 29.601 0,37% Aktien
NewEdge Advisors, LLC $195.409 26.300 0,34% Aktien
GEODE CAPITAL MANAGEMENT, LLC $137.655 18.527 0,24% Aktien
AXQ CAPITAL, LP $118.390 15.934 0,20% Aktien
SUSQUEHANNA INTERNATIONAL GROUP, LLP $92.132 12.400 0,16% Kaufoption
Granite Investment Partners, LLC $87.050 11.716 0,15% Aktien
NEW YORK STATE COMMON RETIREMENT FUND $83.461 11.233 0,14% Aktien
QRG CAPITAL MANAGEMENT, INC. $80.801 10.875 0,14% Aktien
JANE STREET GROUP, LLC $75.786 10.200 0,13% Verkaufsoption
Teton Advisors, LLC $74.300 10.000 0,13% Aktien
GAMMA Investing LLC $60.748 8.176 0,11% Aktien
Teton Advisors, Inc. $56.500 10.000 0,10% Aktien
RHUMBLINE ADVISERS $35.319 4.754 0,06% Aktien
Federation des caisses Desjardins du Quebec $26.048 3.508 0,05% Aktien
State of Tennessee, Department of Treasury $25.849 3.479 0,04% Aktien
OSAIC HOLDINGS, INC. $21.918 2.950 0,04% Aktien
BlackRock, Inc. $15.833 2.131 0,03% Aktien
ROYAL BANK OF CANADA $13.000 1.715 0,02% Aktien
CoreCap Advisors, LLC $9.288 1.250 0,02% Aktien
SIMPLEX TRADING, LLC $5.260 708 0,01% Aktien

Alle 66 institutionellen Eigentümer anzeigen →

Aktivisten & 5%+-Eigentümer 1 Beteiligung

18

Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.

Anmelder Eingereicht Beteiligung Status Zweck Einreichung
Wilfried Vancraen, Hilde Ingelaere, Idem ×5 Einreichungen 30. Oktober 2025 57,60% Änderung · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF-Besitz Gehalten von 2 ETFs

20

Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.

Fonds Gewicht Anteile Stand Quelle
PRNT · ARK ETF Trust 3,70% 342.123 NS 31. Juli 2026 N-PORT
BULD · Pacer Funds Trust 1,86% 43.572 NS 31. Juli 2026 N-PORT

MTLS Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial

21
Bewertung · 9 Analysten KAUF
Median-Ziel $8.81 +3,6%
4 44,4% Starker Kauf
4 44,4% Kauf
1 11,1% Halten
0 0,0% Verkauf
0 0,0% Starker Verkauf

12-Monats-Kursziel

3 Analysten · 2026-09-30

Mittelwert-Ziel $8.81 +3,6%

Jetzt Aktueller Preis $8.50
Tief$7.88 Mittelwert$8.81 Hoch$9.73

Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten

26

Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.

Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.

Quelle: SEC 20-F eingereicht Apr 23, 2026